Radolfzell, Germany

Thomas Fuchss

USPTO Granted Patents = 6 

Average Co-Inventor Count = 1.7

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Constance, DE (2004)
  • Radolfzell, DE (2008 - 2010)

Company Filing History:


Years Active: 2004-2010

Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Thomas Fuchss

Introduction

Thomas Fuchss is a notable inventor based in Radolfzell, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that serve as inhibitors for specific enzymes. With a total of six patents to his name, Fuchss has established himself as a key figure in his area of expertise.

Latest Patents

Among his latest patents are the "Imidazopyridine derivatives useful as iNOS inhibitors." These compounds, defined by the formula (I) where R1, R11, and A have specific meanings, are recognized as novel and effective inhibitors of the enzyme iNOS. Another significant patent is for "Aminopyridine-derivatives," which also features a formula (I) with defined variables R1, R2, R3, and R4, showcasing their effectiveness as iNOS inhibitors.

Career Highlights

Fuchss has worked with prominent companies in the pharmaceutical industry, including Altana Pharma AG and Nycomed GmbH. His experience in these organizations has allowed him to contribute to the development of innovative medical solutions.

Collaborations

Throughout his career, Thomas Fuchss has collaborated with esteemed colleagues such as Wolf-Rüdiger Ulrich and Christian Scheufler. These partnerships have further enhanced his research and development efforts.

Conclusion

In summary, Thomas Fuchss is a distinguished inventor whose work in developing iNOS inhibitors has made a significant impact in the pharmaceutical field. His patents and collaborations reflect his commitment to innovation and excellence in research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…